Noncoding CGG repeat expansions in neuronal intranuclear inclusion disease, oculopharyngodistal myopathy and an overlapping disease.


Journal

Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904

Informations de publication

Date de publication:
08 2019
Historique:
received: 30 08 2018
accepted: 29 05 2019
pubmed: 25 7 2019
medline: 29 1 2020
entrez: 24 7 2019
Statut: ppublish

Résumé

Noncoding repeat expansions cause various neuromuscular diseases, including myotonic dystrophies, fragile X tremor/ataxia syndrome, some spinocerebellar ataxias, amyotrophic lateral sclerosis and benign adult familial myoclonic epilepsies. Inspired by the striking similarities in the clinical and neuroimaging findings between neuronal intranuclear inclusion disease (NIID) and fragile X tremor/ataxia syndrome caused by noncoding CGG repeat expansions in FMR1, we directly searched for repeat expansion mutations and identified noncoding CGG repeat expansions in NBPF19 (NOTCH2NLC) as the causative mutations for NIID. Further prompted by the similarities in the clinical and neuroimaging findings with NIID, we identified similar noncoding CGG repeat expansions in two other diseases: oculopharyngeal myopathy with leukoencephalopathy and oculopharyngodistal myopathy, in LOC642361/NUTM2B-AS1 and LRP12, respectively. These findings expand our knowledge of the clinical spectra of diseases caused by expansions of the same repeat motif, and further highlight how directly searching for expanded repeats can help identify mutations underlying diseases.

Identifiants

pubmed: 31332380
doi: 10.1038/s41588-019-0458-z
pii: 10.1038/s41588-019-0458-z
doi:

Substances chimiques

FMR1 protein, human 0
Genetic Markers 0
LRP12 protein, human 0
Low Density Lipoprotein Receptor-Related Protein-1 0
Fragile X Mental Retardation Protein 139135-51-6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1222-1232

Auteurs

Hiroyuki Ishiura (H)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.

Shota Shibata (S)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.

Jun Yoshimura (J)

Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan.

Yuta Suzuki (Y)

Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan.

Wei Qu (W)

Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan.

Koichiro Doi (K)

Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan.
School of Bioscience and Biotechnology, Tokyo University of Technology, Tokyo, Japan.

M Asem Almansour (MA)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.

Junko Kanda Kikuchi (JK)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.

Makiko Taira (M)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.
Department of Integrative Genomics, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.

Jun Mitsui (J)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.
Department of Molecular Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Yuji Takahashi (Y)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.
Department of Neurology, National Center of Neurology and Psychiatry, Tokyo, Japan.

Yaeko Ichikawa (Y)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.
Department of Neurology, Kyorin University, Tokyo, Japan.

Tatsuo Mano (T)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.

Atsushi Iwata (A)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.

Yasuo Harigaya (Y)

Department of Neurology, Maebashi Red Cross Hospital, Maebashi, Japan.

Miho Kawabe Matsukawa (MK)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.

Takashi Matsukawa (T)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.
Department of Molecular Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Masaki Tanaka (M)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.
Institute of Medical Genomics, International University of Health and Welfare, Chiba, Japan.

Yuichiro Shirota (Y)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.

Ryo Ohtomo (R)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.

Hisatomo Kowa (H)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.
Department of Rehabilitation Science, Kobe University Graduate School of Health Sciences, Kobe, Japan.

Hidetoshi Date (H)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.
Department of Neurology, National Center of Neurology and Psychiatry, Tokyo, Japan.

Aki Mitsue (A)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.

Hiroyuki Hatsuta (H)

Department of Neurology and Neuropathology (the Brain Bank for Aging Research), Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo, Japan.
Department of Neurology, Osaka City University Graduate School of Medicine, Osaka, Japan.

Satoru Morimoto (S)

Department of Neurology and Neuropathology (the Brain Bank for Aging Research), Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo, Japan.

Shigeo Murayama (S)

Department of Neurology and Neuropathology (the Brain Bank for Aging Research), Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo, Japan.

Yasushi Shiio (Y)

Department of Neurology, Tokyo Teishin Hospital, Tokyo, Japan.

Yuko Saito (Y)

Department of Pathology and Laboratory Medicine, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.

Akihiko Mitsutake (A)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.

Mizuho Kawai (M)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.

Takuya Sasaki (T)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.

Yusuke Sugiyama (Y)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.

Masashi Hamada (M)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.

Gaku Ohtomo (G)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.

Yasuo Terao (Y)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.
Department of Cell Physiology, Kyorin University School of Medicine, Tokyo, Japan.

Yoshihiko Nakazato (Y)

Department of Neurology, Saitama Medical University, Saitama, Japan.

Akitoshi Takeda (A)

Department of Neurology, Osaka City University Graduate School of Medicine, Osaka, Japan.

Yoshio Sakiyama (Y)

Department of Neurology, Jichi Medical University, Saitama Medical Center, Saitama, Japan.

Yumi Umeda-Kameyama (Y)

Department of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Jun Shinmi (J)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.

Katsuhisa Ogata (K)

Department of Neurology, National Hospital Organization Higashisaitama Hospital, Saitama, Japan.

Yutaka Kohno (Y)

Department of Neurology, Ibaraki Prefectural University of Health Sciences, Ami, Japan.

Shen-Yang Lim (SY)

Division of Neurology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Ai Huey Tan (AH)

Division of Neurology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Jun Shimizu (J)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.

Jun Goto (J)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.
Department of Neurology, International University of Health and Welfare Mita Hospital, Tokyo, Japan.

Ichizo Nishino (I)

Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.

Tatsushi Toda (T)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan.

Shinichi Morishita (S)

Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan.

Shoji Tsuji (S)

Department of Neurology, The University of Tokyo Hospital, Tokyo, Japan. tsuji@m.u-tokyo.ac.jp.
Department of Molecular Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. tsuji@m.u-tokyo.ac.jp.
Institute of Medical Genomics, International University of Health and Welfare, Chiba, Japan. tsuji@m.u-tokyo.ac.jp.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH